• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IRHYTHM TECHNOLOGIES, INC ZIO AT; DETECTOR AND ALARM, ARRHYTHMIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IRHYTHM TECHNOLOGIES, INC ZIO AT; DETECTOR AND ALARM, ARRHYTHMIA Back to Search Results
Device Problem Failure to Transmit Record (1521)
Patient Problem Unspecified Heart Problem (4454)
Event Date 11/12/2023
Event Type  malfunction  
Manufacturer Narrative
The device was worn for 11 days of the 14-day prescribed wear-period.The device reached the asymptomatic maximum transmission limit and stopped transmitting asymptomatic events on day 10.The hcp account was notified on day 8 that the device was approaching the asymptomatic transmission limit, and a replacement device was declined.Irhythm became aware of the arrhythmia while preparing final report and notified the hcp on day 27.As described in product labeling, the zio at device has a maximum threshold of transmitting 100 patient triggers and 500 asymptomatic transmissions during wear.When a patient is approaching the limit for either transmission type, irhythm reaches out to the account to determine whether to send another at device to the patient.Patient-triggered symptomatic transmissions are still able to be transmitted beyond this limit by pressing the large central button located on the outer device housing.This event is being reported per 21cfr 803 as a product problem /malfunction.This report does not constitute an admission by irhythm that the product described in this report has any defects or has malfunctioned.These terms are included in form fda 3500a and are fixed terms for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.
 
Event Description
The patient experienced an arrhythmia that met medical doctor notification (mdn) requirements that was not transmitted during the wear period.The investigation confirmed the zio at reached the asymptomatic maximum transmission limit.The hcp account was notified that the device was approaching the asymptomatic transmission limit prior to reaching the limit, according to the standard process, and a replacement device was shipped.No adverse events, such as death or serious injury, are known to have occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZIO AT
Type of Device
DETECTOR AND ALARM, ARRHYTHMIA
Manufacturer (Section D)
IRHYTHM TECHNOLOGIES, INC
699 8th st suite 600
san francisco CA 94103
Manufacturer (Section G)
IRHYTHM TECHNOLOGIES, INC
6550 katella avenue, suite 200
cypress CA 90630
Manufacturer Contact
mazi kiani
699 8th st suite 600
san francisco, CA 94103
MDR Report Key18360824
MDR Text Key331195346
Report Number3007208829-2023-00199
Device Sequence Number1
Product Code DSI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K163512
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 12/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/19/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date03/13/2024
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/24/2023
Date Manufacturer Received11/29/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/15/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age76 YR
Patient SexMale
-
-